Exit valuation of Ohmic Biosciences (YC S23)? | Manifold

Exit valuation of Ohmic Biosciences (YC S23)?

1

120Ṁ30

2100

59%

Less than $10M or bankrupt

14%

$10M - $100M

14%

$100M - $1B

14%

$1B+

When Ohmic Biosciences goes bankrupt, gets acquired, or goes public with an IPO, what will its valuation be?

https://www.ycombinator.com/companies/ohmic-biosciences

Ohmic Biosciences: Genetically engineering plants for disease resistance. | Y Combinator

Genetically engineering plants for disease resistance. Founded in 2021 by Matthew Bedewitz and PJ Steiner, Ohmic Biosciences has 2 employees based in Alameda, CA, USA.

Get

1,000

to start trading!

Related questions

Exit valuation of Dioxus Labs (YC S23)?

Exit valuation of Feanix Biotechnologies (YC S23)?

Exit valuation of Olio Labs (YC S23)?

Exit valuation of Certainly Health (YC S23)?

Exit valuation of Kobalt Labs (YC S23)?

Exit valuation of MantleBio (YC S23)?

Exit valuation of Healthtech 1 (YC S23)?

Exit valuation of Obento Health (YC S23)?

Exit valuation of Decoda Health (YC S23)?

Exit valuation of Empirical Health (YC S23)?

Related questions

Exit valuation of Dioxus Labs (YC S23)?

Exit valuation of MantleBio (YC S23)?

Exit valuation of Feanix Biotechnologies (YC S23)?

Exit valuation of Healthtech 1 (YC S23)?

Exit valuation of Olio Labs (YC S23)?

Exit valuation of Obento Health (YC S23)?

Exit valuation of Certainly Health (YC S23)?

Exit valuation of Decoda Health (YC S23)?

Exit valuation of Kobalt Labs (YC S23)?

Exit valuation of Empirical Health (YC S23)?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules